Health Care & Life Sciences » Pharmaceuticals | Godavari Drugs Ltd.

Godavari Drugs Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,379.40
2,634.30
6,503.70
8,827.90
16,162.70
Total Accounts Receivable
20,352.80
164,431.10
283,280.90
293,780.10
306,563.70
Inventories
30,367.60
100,536.40
112,807.60
122,322.20
145,667.50
Other Current Assets
12,701.10
1,006.90
1,378.00
1,354.50
1,817.30
Total Current Assets
67,800.90
268,608.70
403,970.20
426,284.70
470,211.30
Net Property, Plant & Equipment
78,943.90
76,931.40
99,227.50
128,850.10
155,218.10
Total Investments and Advances
1.00
1,867.80
1.00
1.00
1.00
Other Assets
3,107.80
-
2,247.40
1,866.80
2,126.80
Total Assets
158,671.90
348,543.20
506,814.10
557,002.50
627,557.20
ST Debt & Current Portion LT Debt
-
48,394.50
115,938.80
113,728.60
115,813.00
Accounts Payable
4,856.10
87,793.90
173,567.10
200,596.80
230,209.50
Income Tax Payable
-
2,987.50
-
525.90
-
Other Current Liabilities
27,489.40
31,897.70
21,220.00
20,144.20
26,034.10
Total Current Liabilities
32,345.50
171,073.50
310,725.90
334,995.40
372,056.70
Long-Term Debt
24,167.50
36,428.00
39,174.10
43,857.20
65,996.10
Provision for Risks & Charges
2,147.80
3,135.70
3,348.00
3,911.80
4,806.10
Deferred Taxes
3,892.70
6,178.90
8,095.70
12,043.50
14,209.80
Total Liabilities
63,586.50
217,951.50
362,711.60
394,807.90
457,068.80
Common Equity (Total)
87,931.40
123,437.70
136,948.50
156,694.60
164,988.40
Total Shareholders' Equity
87,931.40
123,437.70
136,948.50
156,694.60
164,988.40
Total Equity
87,931.40
123,437.70
136,948.50
156,694.60
164,988.40
Liabilities & Shareholders' Equity
158,671.90
348,543.20
506,814.10
557,002.50
627,557.20
Non-Equity Reserves
7,154.00
7,154.00
7,154.00
5,500.00
5,500.00

About Godavari Drugs

View Profile
Address
1st Floor, Mayfair
Secunderabad TS 500003
India
Employees -
Website http://www.godavaridrugs.com
Updated 09/14/2018
Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride, Ethambutol Hydrochloride, A D Lactone, and Benzhyryl Piperazine. The company was founded on December 2, 1987 and is headquartered in Secunderabad, India.